Financial Snapshot: Analyzing Y-Mabs Therapeutics Inc (YMAB)’s Key Ratio Metrics

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

The closing price of Y-Mabs Therapeutics Inc (NASDAQ: YMAB) was $4.96 for the day, down -4.43% from the previous closing price of $5.19. In other words, the price has decreased by -$4.43 from its previous closing price. On the day, 0.66 million shares were traded.

Ratios:

Our analysis of YMAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.54 and its Current Ratio is at 3.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on November 18, 2024, initiated with a Outperform rating and assigned the stock a target price of $23.

On August 16, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $20.

On June 28, 2024, Truist started tracking the stock assigning a Buy rating and target price of $21.Truist initiated its Buy rating on June 28, 2024, with a $21 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 13 ’24 when Gad Thomas sold 65,000 shares for $13.47 per share. The transaction valued at 875,550 led to the insider holds 97,681 shares of the business.

Gad Thomas sold 30,000 shares of YMAB for $389,100 on Sep 16 ’24. The CHIEF BUSINESS OFFICER now owns 67,681 shares after completing the transaction at $12.97 per share. On Sep 13 ’24, another insider, Thomas Gad, who serves as the Officer of the company, bought 100,000 shares for $13.74 each.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.63 while its Price-to-Book (P/B) ratio in mrq is 2.40.

Stock Price History:

Over the past 52 weeks, YMAB has reached a high of $19.12, while it has fallen to a 52-week low of $5.13. The 50-Day Moving Average of the stock is -24.65%, while the 200-Day Moving Average is calculated to be -55.35%.

Shares Statistics:

A total of 44.77M shares are outstanding, with a floating share count of 34.11M. Insiders hold about 23.85% of the company’s shares, while institutions hold 60.61% stake in the company.

Most Popular